Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma

M. Konareva-Kostianeva, S. Kostianev, P. Strumeliev (Plovdiv, Bulgaria)

Source: Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Session: Asthma: Inflammation, hyperreactivity, treatment side effects
Session type: Thematic Poster Session
Number: 433
Disease area: Airway diseases

Congress or journal article abstract

Abstract

The aim of this study was to investigate the influence of inhaled corticosteroids (ICS) on intraocular pressure (IOP) in asthmatics with primary open angle glaucoma with and without family history of glaucoma. Three hundred and five glaucomatous patients with visual field defects, optic disc changes and elevated IOP and 145 control subjects participated in the study. Twenty asthmatics treated with ICS were found to form three groups: I group - 4 asthmatics with glaucoma that have family history of glaucoma, II group - 9 asthmatics with glaucoma without family history of glaucoma and III group - 7 asthmatics without glaucoma. The asthmatic patients with glaucoma and family history have higher IOP than those with glaucoma without family history - IOP mmHg = 26.6±]2.7 vs. 23.2±]3.6 (p<0.05) and showed more severe visual field defects - Mean Deviation 7.6±]4.1 vs 2.7±]2.8 (p<0.05). IOP was normal (16.0±]3.1 mm Hg) in all asthmatics without glaucoma except one subject who showed an ocular hypertensive response to ICS. The results support the hypothesis that the patients with family glaucoma inherit not only glaucoma disease but also increased susceptibility to corticosteroids. In conclusion, glaucomatous asthmatics on ICS, exspecially those with family history of glaucoma, need special care and follow-up by ophthalmologist.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Konareva-Kostianeva, S. Kostianev, P. Strumeliev (Plovdiv, Bulgaria). Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma. Eur Respir J 2002; 20: Suppl. 38, 433

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of inhaled fluticason propionate on intraocular pressure of patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Source: Eur Respir J 2006; 27: 1168-1174
Year: 2006



Intraocular pressure and occurrence of cataracts in children treated for a mean of 16 years with inhaled budesonide
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010

Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Intraocular pressure in glaucoma patients varied considerably after nasal CPAP compared to control subjects
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003


Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010

Evaluation of ocular complications of long-term inhaled steroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 97s
Year: 2001

Ipratropium bromide effects on intraocular pressure in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 287s
Year: 2005

Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008

CPAP related intraocular pressure increase at night in people with and without glaucoma.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018


Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Impact of inhaled corticosteroids in patients with cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 251-263
Year: 2020


Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Effectiveness of nebulizing heliox coupled to bronchodilators and body positioning in severe asthma patients
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009

Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010


Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001

Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002